Pharscin Pharma Gets Nod to Re-Register Eight Products

Chongqing Pharscin Pharmaceutical Gets Re-approval for Proton Pump Inhibitor

Pharscin Pharmaceutical Completes Drug Filing Application for Rasagiline Mesylate Tablets; Shares Down 3%

Chongqing Pharscin Pharmaceutical (002907.SZ) Completes Domestic Production Filing for Rasagiline Mesylate Tablets

Pharscin Pharmaceutical Renews Manufacturing License

Pharscin Pharmaceutical's Liquid Food Formula for Digestive Disorders Gets China Approval

Chongqing Pharscin Pharmaceutical (002907.SZ) Obtains Registration Certificate for Special Medical Use Formula Food

Chongqing Pharscin Pharmaceutical (002907.SZ) Reports Q3 Results: Net Profit Attributable to Shareholders Drops 2.84% YoY to RMB 72.46 Million

Pharscin Pharmaceutical Gets Approval Generic Lung Cancer Drug

Chongqing Pharscin Pharmaceutical Co.,Ltd. (002907.SZ) Obtains Drug Registration Certificate for Crizotinib Capsules

Chongqing Pharscin Pharmaceutical Says Chairman and Shareholder Plan to Unload up to Combined 3% Stakes in Co Between November 6 and February 5, 2026

BRIEF-Chongqing Pharscin Pharmaceutical's Chairman, Shareholder Plan To Unload Stakes

Chongqing Pharscin Pharmaceutical Gets China Municipal Drug Approval for Hepatitis, Blood Circulation Drugs

Chongqing Pharscin Pharmaceutical (002907.SZ) Receives Drug Re-registration Approval Notices

Pharscin Pharmaceutical Gets Extension for Two Drug Manufacturing Licenses1

Pharscin Pharmaceutical Gets Nod to Become Authorized Marketer of Jian'er Xiaoshi Oral Liquid

Pharscin Pharmaceutical Pays 10 Million Yuan in Back Taxes, Late Fees

Chongqing Pharscin Pharmaceutical Gets China Re-Registration Approval for Three Drugs